Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diabetes: Add-on to metformin in T2DM--linagliptin or glimepiride?

× No keyword cloud information.

10 in total

1. Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes.

Authors: L Landstedt-Hallin; U Adamson; P E Lins
Journal: J Clin Endocrinol Metab Date: 1999-09 Impact factor: 5.958

2. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors: S E Inzucchi; R M Bergenstal; J B Buse; M Diamant; E Ferrannini; M Nauck; A L Peters; A Tsapas; R Wender; D R Matthews
Journal: Diabetologia Date: 2012-04-20 Impact factor: 10.122

3. Differential effects of sulfonylurea derivatives on vascular ATP-sensitive potassium channels.

Authors: Richard Engbersen; Rosalinde Masereeuw; Miriam A van Gestel; Helene L M Siero; Miek M Moons; Paul Smits; Frans G M Russel
Journal: Eur J Pharmacol Date: 2012-02-17 Impact factor: 4.432

4. 2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial.

Authors: Baptist Gallwitz; Julio Rosenstock; Thomas Rauch; Sudipta Bhattacharya; Sanjay Patel; Maximilian von Eynatten; Klaus A Dugi; Hans-Juergen Woerle
Journal: Lancet Date: 2012-06-28 Impact factor: 79.321

Review 5. The effect of glucagon-like peptide 1 on cardiovascular risk.

Authors: Jacob Sivertsen; Jaya Rosenmeier; Jens J Holst; Tina Vilsbøll
Journal: Nat Rev Cardiol Date: 2012-01-31 Impact factor: 32.419

6. Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes.

Authors: Bo Ahrén; Anja Schweizer; Sylvie Dejager; Beth E Dunning; Peter M Nilsson; Margaretha Persson; James E Foley
Journal: J Clin Endocrinol Metab Date: 2009-01-27 Impact factor: 5.958

7. Sulfonylurea induced beta-cell apoptosis in cultured human islets.

Authors: Kathrin Maedler; Richard D Carr; Domenico Bosco; Richard A Zuellig; Thierry Berney; Marc Y Donath
Journal: J Clin Endocrinol Metab Date: 2004-10-13 Impact factor: 5.958

8. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group.

Authors:
Journal: Diabetes Date: 1995-11 Impact factor: 9.461

9. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.

Authors:
Journal: Diabetologia Date: 2007-04-06 Impact factor: 10.122

10. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study.

Authors: Denise E Bonds; Michael E Miller; Richard M Bergenstal; John B Buse; Robert P Byington; Jeff A Cutler; R James Dudl; Faramarz Ismail-Beigi; Angela R Kimel; Byron Hoogwerf; Karen R Horowitz; Peter J Savage; Elizabeth R Seaquist; Debra L Simmons; William I Sivitz; Joann M Speril-Hillen; Mary Ellen Sweeney
Journal: BMJ Date: 2010-01-08

10 in total